131 related articles for article (PubMed ID: 22458519)
1. Molecular and genetic bases of pancreatic cancer.
Vaccaro V; Gelibter A; Bria E; Iapicca P; Cappello P; Di Modugno F; Pino MS; Nuzzo C; Cognetti F; Novelli F; Nistico P; Milella M
Curr Drug Targets; 2012 Jun; 13(6):731-43. PubMed ID: 22458519
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches to target pancreatic cancer.
Porzner M; Seufferlein T
Curr Cancer Drug Targets; 2011 Jul; 11(6):698-713. PubMed ID: 21599630
[TBL] [Abstract][Full Text] [Related]
3. Targeting EGFR in pancreatic cancer treatment.
Troiani T; Martinelli E; Capasso A; Morgillo F; Orditura M; De Vita F; Ciardiello F
Curr Drug Targets; 2012 Jun; 13(6):802-10. PubMed ID: 22458527
[TBL] [Abstract][Full Text] [Related]
4. Target therapies in pancreatic carcinoma.
Silvestris N; Gnoni A; Brunetti AE; Vincenti L; Santini D; Tonini G; Merchionne F; Maiello E; Lorusso V; Nardulli P; Azzariti A; Reni M
Curr Med Chem; 2014; 21(8):948-65. PubMed ID: 23992319
[TBL] [Abstract][Full Text] [Related]
5. [Recent update of molecular targeted therapy in pancreatic cancer].
Cho JH
Korean J Gastroenterol; 2013 Mar; 61(3):147-54. PubMed ID: 23575233
[TBL] [Abstract][Full Text] [Related]
6. Possible role of epidermal growth factor receptors in the therapy of pancreatic cancer.
Aggarwal S; Gupta S; Gupta MK; Murthy RS; Vyas SP
Crit Rev Ther Drug Carrier Syst; 2011; 28(4):293-356. PubMed ID: 21967400
[TBL] [Abstract][Full Text] [Related]
7. EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies.
Nedaeinia R; Avan A; Manian M; Salehi R; Ghayour-Mobarhan M
Curr Drug Targets; 2014; 15(14):1293-301. PubMed ID: 25429712
[TBL] [Abstract][Full Text] [Related]
8. Development of epidermal growth factor receptor targeted therapy in pancreatic cancer.
Qing L; Qing W
Minerva Chir; 2018 Oct; 73(5):488-496. PubMed ID: 29397631
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
10. Targeting Epidermal Growth Factor Receptor-Related Signaling Pathways in Pancreatic Cancer.
Philip PA; Lutz MP
Pancreas; 2015 Oct; 44(7):1046-52. PubMed ID: 26355547
[TBL] [Abstract][Full Text] [Related]
11. Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.
Sahin IH; Iacobuzio-Donahue CA; O'Reilly EM
Expert Opin Ther Targets; 2016; 20(3):341-59. PubMed ID: 26439702
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor: is a novel therapeutic target for pancreatic cancer?
Dhar A; Mehta S; Banerjee S; Dhar K; Dhar G; Sengupta K; Ray G; Banerjee SK; Campbell DR
Front Biosci; 2005 May; 10():1763-7. PubMed ID: 15769665
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of apoptosis: promising therapy in pancreatic cancer.
Liu Z; Li D; Zheng X; Wang E; Wang J
Curr Pharm Des; 2013; 19(12):2259-68. PubMed ID: 23082976
[TBL] [Abstract][Full Text] [Related]
14. Advanced or metastatic pancreatic cancer: molecular targeted therapies.
Bayraktar S; Rocha-Lima CM
Mt Sinai J Med; 2010; 77(6):606-19. PubMed ID: 21105124
[TBL] [Abstract][Full Text] [Related]
15. Role of epidermal growth factor gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of pancreatic carcinoma.
Muslimov GF
Bull Exp Biol Med; 2008 Apr; 145(4):535-8. PubMed ID: 19110611
[TBL] [Abstract][Full Text] [Related]
16. New target therapies in advanced pancreatic cancer.
Cascinu S; Verdecchia L; Valeri N; Berardi R; Scartozzi M
Ann Oncol; 2006 May; 17 Suppl 5():v148-52. PubMed ID: 16807445
[TBL] [Abstract][Full Text] [Related]
17. Emerging pathways and future targets for the molecular therapy of pancreatic cancer.
Vaccaro V; Melisi D; Bria E; Cuppone F; Ciuffreda L; Pino MS; Gelibter A; Tortora G; Cognetti F; Milella M
Expert Opin Ther Targets; 2011 Oct; 15(10):1183-96. PubMed ID: 21819318
[TBL] [Abstract][Full Text] [Related]
18. Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review.
Zagouri F; Sergentanis TN; Chrysikos D; Zografos CG; Papadimitriou CA; Dimopoulos MA; Filipits M; Bartsch R
Pancreas; 2013 Jul; 42(5):760-73. PubMed ID: 23774698
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies.
Matsuoka T; Yashiro M
World J Gastroenterol; 2016 Jan; 22(2):776-89. PubMed ID: 26811624
[TBL] [Abstract][Full Text] [Related]
20. Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway.
Yang L; Lin S; Kang Y; Xiang Y; Xu L; Li J; Dai X; Liang G; Huang X; Zhao C
J Exp Clin Cancer Res; 2019 Jan; 38(1):31. PubMed ID: 30674340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
